Immunotherapy of bladder tumors Academic Article uri icon

Overview

MeSH Major

  • Immunotherapy
  • Urinary Bladder Neoplasms

abstract

  • Immunotherapy has been applied topically, intralesionally and systemically in the treatment of local, regional, and metastatic bladder cancer. Results from multiple clinical trials conducted in the past 10 years have been disappointing in patients with locally advanced or disseminated disease, but immunotherapy has contributed significantly to the successful treatment of superficial bladder tumors. Immunotherapy offers improved means of eradicating existing tumors and, more important, preventing potentially life-threatening new tumor occurrences by favorably altering preneoplastic lesions (chemoprevention).

publication date

  • December 1984

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 6400156

Additional Document Info

start page

  • 257

end page

  • 61

volume

  • 8

number

  • 3-4